Concepedia

Mallesh Pandrala

MP

Statistics

Publications

15

Citations

363

H-Index

13

Active since

2013

Affiliations

Stanford University(Current)

Oregon Health & Science University

Stanford Medicine

UNSW Sydney

Australian Defence Force Academy

Mallesh Pandrala is an author at Stanford University specializing in oncology, pharmacology, and molecular oncology.

ORCID

Publications per year

2013–2024

15

Publications

15

Chlorido-containing ruthenium(ii) and iridium(iii) complexes as antimicrobial agents

Mallesh Pandrala, Fangfei Li, Marshall Feterl et al. · Dalton Transactions · 2013 · 71 citations

, , +17

Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer

Dhanir Tailor, Angel Resendez, Fernando Jose Garcia-Marques et al. · Cell chemical biology · 2021 · 52 citations · Full text

, , +14

SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer

Meghan A. Rice, Vineet Kumar, Dhanir Tailor et al. · Cell Reports Medicine · 2022 · 35 citations · Full text

, , +17

Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy

Arpit Dheeraj, Fernando Jose Garcia-Marques, Dhanir Tailor et al. · Cell Reports Medicine · 2024 · 24 citations · Full text

, , +17

Quantitative Proteomic Profiling Reveals Key Pathways in the Anticancer Action of Methoxychalcone Derivatives in Triple Negative Breast Cancer

Catherine C. Going, Dhanir Tailor, Vineet Kumar et al. · Journal of Proteome Research · 2018 · 23 citations · Full text

, , +16

1–5 of 15